Evaluation of the cytotoxic and genotoxic effects of Sida planicaulis Cav extract using human neuroblastoma cell line SH-SY5Y

Sida planicaulis is a weed thought to have originated in Brazil, the place it’s current in considerable portions, but in addition this plant can also be present in south-central Florida, Indian Ocean Islands, and the Pacific Islands. Sida planicaulis produces neurotoxicity that adversely impacts livestock breeding with heavy animal losses and consequent destructive affect on Brazil’s economic system.

The intention of this research was to find out the chemical profile, cytotoxic and genotoxic results of ethanolic extracts of S. planicaulis collected in winter (leaf extract) and summer season (leaf extract and leaf + flower extract) utilizing an in vitro mannequin of human neuroblastoma cell line SH-SY5Y. Phytochemical screening demonstrated the presence of alkaloids, flavonoids, and apolar compounds.

Rutin, quercetin, and swainsonine had been detected by HPLC and GC/MS, respectively. Phosphorus, potassium, iron, and zinc had been the inorganic parts discovered. Extracts produced cytotoxicity in any respect concentrations examined (7-4,000 μg/ml) as evidenced by the colorimetric assay [3-(4,5-dimethyl-thiazol-2-yl) -2,5-diphenyl-tetrazolium bromide (MTT)]. Based mostly upon the alkaline comet assay extracts had been discovered to induce genotoxicity at concentrations starting from 0.437 to 7 μg/ml.

DNA harm produced by extracts was affirmed utilizing a modified comet assay with the enzymes Endo III and FPG in a focus dependent method. Additional, enzyme-modified comet assay confirmed each oxidized purines and pyrimidines, and consequently oxidative stress was associated to genomic instability and cell demise. Information counsel that low concentrations of ethanolic extracts of S. planicaulis (completely different seasons) induced elevated DNA harm associated to oxidative stress and chemical composition.

CELL CYCLE STRESS IN NORMAL HUMAN CELLS: A ROUTE TO “FIRST CELLS” (WITH/WITHOUT FITNESS GAIN) AND CANCER-LIKE CELL-SHAPE CHANGES

We’ve introduced an in vitro trackable mannequin system, atavistic induced from conservation in our genome, which strongly is relevant to tumorigenesis begin and evolution. The inducing issue was demise alerts to proliferating regular human cells (major cell strains), which respon-ded by a particular kind of tetraploidization, chromosomes with 4-chromatids (diplochromosomes, earlier described in most cancers cells).

The response included cell cycle stress, which extended S-period with results of mitotic slippage course of, forming the particular 4n cells by re-replication of diploid cells, which confirmed cell division functionality to sudden, genome diminished diploid cells which remarkably, confirmed health acquire. This distinctive response by means of cell cycle stress and mitotic slippage course of was additional found to be linked to a somewhat particular attribute of the, 4n nucleus.

The nucleus turned, self-inflicted, 90° perpendicular to the cell’s cytoskeleton axis, importantly, earlier than the particular 4n-division system produced genome scale back diploid cells, we name “first cells”, due to health acquire. These 2n cells additionally confirmed the nuclear dependent 90° flip, which in each circumstances was related to cells gaining cell form modifications, herein illustrated from regular fibroblastic cells altering to roundness cells, indistinguishable from todays’ diagnostic most cancers cell morphology. This 3-D ball-like cell form, in metastasis, sque-ezing out and in between (?) endothelial cells within the lining of blood veins throughout disbursement, can be advantageous.

Familial Alzheimer’s Illness Mutations in PSEN1 Result in Untimely Human Stem Cell Neurogenesis

Mutations in presenilin 1 (PSEN1) or presenilin 2 (PSEN2), the catalytic subunit of γ-secretase, trigger familial Alzheimer’s illness (fAD). We hypothesized that mutations in PSEN1 scale back Notch signaling and alter neurogenesis. Expression knowledge from developmental and grownup neurogenesis present relative enrichment of Notch and γ-secretase expression in stem cells, whereas expression of APP and β-secretase is enriched in neurons.

We observe untimely neurogenesis in fAD iPSCs harboring PSEN1 mutations utilizing two orthogonal methods: cortical differentiation in 2D and cerebral organoid technology in 3D. That is partly pushed by diminished Notch signaling. We prolong these research to grownup hippocampal neurogenesis in mutation-confirmed postmortem tissue. fAD circumstances present mutation-specific results and a pattern towards diminished abundance of new child neurons, supporting a untimely getting old phenotype. Altogether, these outcomes help altered neurogenesis on account of fAD mutations and counsel that neural stem cell biology is affected in getting old and illness.

Evaluation of the cytotoxic and genotoxic effects of Sida planicaulis Cav extract using human neuroblastoma cell line SH-SY5Y

Knockdown of TRIM5α or TRIM11 will increase lentiviral vector transduction effectivity of human muller cells

The purpose of this research was to find out the expression and distribution of the host restriction elements (RFs) TRIM5α and TRIM11 in non-human primate (NHP) neural retina tissue and the human Muller cell line MIO-M1. As well as, experiments had been carried out to find out the impact of TRIM5α and TRIM11 knockdown on FIVGFP transduction of MIO-M1 cells with the purpose of devising methods to extend the effectivity of lentiviral (LV) gene supply vectors.

Immunofluorescence (IF) research indicated that TRIM5α and TRIM11 had been localized predominantly in nuclei inside the outer nuclear layer (ONL) and interior nuclear layer (INL) of NHP retina tissue. Double label IF indicated that TRIM5α and TRIM11 had been localized to among the retinal Muller cell nuclei. MIO-M1 cells expressed TRIM5α predominantly within the nucleus and TRIM11 primarily within the cytosol. FIVGFP transduction effectivity was considerably elevated, at Four and seven days put up transduction, in TRIM5α and TRIM11 knockdown clones (KD) in comparison with WT MIO-M1 cells.

As well as, pretreatment with the proteasome inhibitor MG132 elevated the transduction effectivity of FIVGFP in WT MIO-M1 cells. The nuclear translocation of NF-κB (p65), at 72 h put up FIVGFP transduction, was enhanced in TRIM5α and TRIM11 KD clones. The expression of TRIM5α and TRIM11 in macaque neural retina tissue and MIO-M1 cells point out the presence of those RFs in NHP retina and human Muller cells.

Monocyte differentiation antigen CD14

AP81659 1mg
EUR 2640

Monocyte differentiation antigen CD14

AP81660 1mg
EUR 2640

CD14. MONOCYTE. MACROPHAGE MARKER, Antibody

GWB-37CA39 0.1 mg Ask for price

CD14. MONOCYTE. MACROPHAGE MARKER, Antibody

GWB-9F79F9 0.1 mg Ask for price

CD14. MONOCYTE. MACROPHAGE MARKER, Antibody

GWB-ED63C8 0.1 mg Ask for price

Human Monocyte differentiation antigen CD14 (CD14)

1-CSB-EP004879HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Monocyte differentiation antigen CD14(CD14),partial expressed in E.coli

Human Monocyte differentiation antigen CD14 (CD14)

1-CSB-MP004879HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Human Monocyte differentiation antigen CD14(CD14) expressed in Mammalian cell

Rat CD45Ra Antibody (B Cells Only)

GWB-6A11BA 0.25 mg Ask for price

Rat CD45Ra Antibody (B Cells Only)

GWB-F09251 1 mg Ask for price

Rat CD45Ra Antibody (B Cells Only)

GWB-D60850 0.1 mg Ask for price

CD14 Antibody (Monocyte and Macrophage Marker)

R32821 100 ug
EUR 356.15
Description: CD14 is a single-copy gene encoding 2 protein forms: a 50- to 55 kDa glycosylphosphatidylinositol-anchored membrane protein (mCD14) and a monocyte or liver-derived soluble serum protein (sCD14) that lacks the anchor. This gene is located at bands 5q23-q31. The protein encoded by this gene is a surface antigen that is preferentially expressed on monocytes/macrophages. CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns.

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx123452
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx134479
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 50 ul

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx137041
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx137121
  • Ask for price
  • Ask for price
  • 0.5 mg
  • 1 mg

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx139167-01mg 0.1 mg
EUR 427.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx139168-01mg 0.1 mg
EUR 427.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx139169-01mg 0.1 mg
EUR 427.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx139170-01mg 0.1 mg
EUR 427.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx006311
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx007883
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ul
  • 200 ul
  • 30 ul

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx036347-100ug 100 ug
EUR 469.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx032787-400ul 400 ul
EUR 627.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx032787-80l 80 µl
EUR 343.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx032788-400ul 400 ul
EUR 627.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx032788-80l 80 µl
EUR 343.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx016101-100ug 100 ug
EUR 493.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx019042-100ug 100 ug
EUR 410.4

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx010514-100ul 100 ul
EUR 493.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx200126-100ug 100 ug
EUR 393.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx210121
  • Ask for price
  • Ask for price
  • 100 ug
  • 50 ug

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx231426-100ug 100 ug
EUR 577.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx231427-100ug 100 ug
EUR 610.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx224038-100ug 100 ug
EUR 493.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

20-abx301355
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx411818-01mg 0.1 mg
EUR 844.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx412836-01mg 0.1 mg
EUR 610.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx413179-02mg 0.2 mg
EUR 678

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx413181-05mg 0.5 mg
EUR 994.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx413184-01mg 0.1 mg
EUR 526.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx413187-25ug 25 ug
EUR 326.4

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx413799-02mg 0.2 mg
EUR 678

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx414467-01mg 0.1 mg
EUR 543.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415241-01mg 0.1 mg
EUR 543.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415258-01mg 0.1 mg
EUR 543.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415260-01mg 0.1 mg
EUR 543.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415287-05mg 0.5 mg
EUR 994.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415289-02mg 0.2 mg
EUR 678

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415290-01mg 0.1 mg
EUR 526.8

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415291-25ug 25 ug
EUR 326.4

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415363-01mg 0.1 mg
EUR 543.6

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx415646-01mg 0.1 mg
EUR 543.6

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159370-100ul 100 ul
EUR 427.2

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159371-100ul 100 ul
EUR 427.2

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159372-100ul 100 ul
EUR 427.2

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159373-100ul 100 ul
EUR 427.2

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159374-100ul 100 ul
EUR 526.8

Monocyte differentiation antigen CD14 (CD14) Antibody

abx159375-100ul 100 ul
EUR 427.2

Monocyte Differentiation Antigen CD14 (CD14) Antibody

abx432465-200ul 200 ul
EUR 460.8

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341024-100l 100 µl
EUR 400

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341024-50l 50 µl
EUR 287.5

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341025-100l 100 µl
EUR 400

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341025-50l 50 µl
EUR 287.5

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341125-100l 100 µl
EUR 350

Monocyte differentiation antigen CD14 (CD14) Antibody

abx341125-50l 50 µl
EUR 250

Human Monocyte-Derived Dendritic Cells

ABC-TC3708 1 vial Ask for price
Description: Human Monocyte-Derived Dendritic Cells provide an ideal culture model for the study of the initiation of immune responses, delivery of antigens to dendritic cells, cytokine production, vaccines and Toll-like receptors (TLRs). Dendritic Cells are derived from monocytes that have been cultured with IL-4 and GM-CSF. Our Dendritic Cells are quality tested via flow cytometry to ensure proper expression of dendritic markers. Dendritic cells express CD11c and HLA-DR. The expression of CD3 (T cells), CD19 (B cells), CD14 (monocytes/macrophages), and CD80 (a maturation marker) is also analyzed to ensure depletion of these cell types. Cell Features:Dendritic Cells are derived from monocytes cultured with interleukin 4 and granulocyte-monocyte colony stimulating factor.Dendritic Cells are extensively tested for quality and optimal performance.Gentaur guarantees performance and quality.

Human Monocyte-Derived Dendritic Cells

CSC-C1676 One Frozen vial Ask for price

CD163 (Monocyte & Macrophage Marker) (M130/1210), 0.2mg/mL

BNUB1210-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker) (M130/1210), 0.2mg/mL

BNUB1210-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2162), 1mg/mL

BNUM2162-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2164), 1mg/mL

BNUM2164-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2162), 0.2mg/mL

BNUB2162-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2162), 0.2mg/mL

BNUB2162-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2164), 0.2mg/mL

BNUB2164-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/2164), 0.2mg/mL

BNUB2164-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker)(M130/1210), 1mg/mL

BNUM1210-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC811210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF680R conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC811210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF680R conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC801210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF680 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC801210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF680 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC431210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF543 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC431210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF543 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC051210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF405M conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC051210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF405M conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC551210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF555 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC551210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF555 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC701210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF770 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC701210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF770 conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC611210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF660R conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNC611210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), CF660R conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCP1210-250 250uL
EUR 472.8
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), PerCP conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCR1210-250 250uL
EUR 472.8
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), RPE conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNUB1210-50 50uL
EUR 486
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), 1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCA1210-250 250uL
EUR 472.8
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), APC conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCH1210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCH1210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCAP1210-100 100uL
EUR 279.6
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD163 (Monocyte & Macrophage Marker) (M130/1210) Antibody

BNCAP1210-500 500uL
EUR 654
Description: Primary antibody against CD163 (Monocyte & Macrophage Marker) (M130/1210), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2385), 1mg/mL

BNUM2385-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2386), 1mg/mL

BNUM2386-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), 1mg/mL

BNUM2397-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2408), 1mg/mL

BNUM2408-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2385), 0.2mg/mL

BNUB2385-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2385), 0.2mg/mL

BNUB2385-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2386), 0.2mg/mL

BNUB2386-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2386), 0.2mg/mL

BNUB2386-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), 0.2mg/mL

BNUB2397-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2397), 0.2mg/mL

BNUB2397-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2408), 0.2mg/mL

BNUB2408-100 100uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2408), 0.2mg/mL

BNUB2408-500 500uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD14 (Monocyte / Macrophage Marker) (LPSR/2385) Antibody

BNC802385-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2385) Antibody

BNC802385-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2386) Antibody

BNC802386-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2386), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2386) Antibody

BNC802386-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2386), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2397) Antibody

BNC802397-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2397) Antibody

BNC802397-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2408) Antibody

BNC802408-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2408) Antibody

BNC802408-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF680 conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2385) Antibody

BNC812385-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2385) Antibody

BNC812385-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2386) Antibody

BNC812386-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2386), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2386) Antibody

BNC812386-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2386), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2397) Antibody

BNC812397-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2397) Antibody

BNC812397-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2397), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2408) Antibody

BNC812408-100 100uL
EUR 279.6
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF680R conjugate, Concentration: 0.1mg/mL

CD14 (Monocyte / Macrophage Marker) (LPSR/2408) Antibody

BNC812408-500 500uL
EUR 654
Description: Primary antibody against CD14 (Monocyte / Macrophage Marker) (LPSR/2408), CF680R conjugate, Concentration: 0.1mg/mL

Our knowledge point out that even partial knockdown of TRIM5α or TRIM11, or a brief proteasome inhibitor pretreatment, can enhance the transduction effectivity of a LV vector.

 

Related Posts

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *